Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience

Global cancer statistics

Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044

Preoperative assessment of liver function: a comparison of 99mTc‐Mebrofenin scintigraphy with indocyanine green clearance test

Erdogan, D., Heijnen, B. H. M., Bennink, R. J., Kok, M., Dinant, S., Straatsburg, I. H., Gouma, D. J., & van Gulik, T. M. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.00901.x · Cited by 11,656

The metabolic syndrome—a new worldwide definition

Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352

Management of Hepatocellular Carcinoma: An Update Δσ

Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,135

Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults

Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696

Prevalence and Trends in Obesity Among US Adults, 1999-2008

Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580

Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation

Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597

Management of Hepatocellular Carcinoma *

Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,913

Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

El‐Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,479

Inflammation and insulin resistance

Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Marrero, J. A., Kulik, L., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,597

EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).

Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210

Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics

Pοlyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2018) · Metabolism · doi:10.1016/j.metabol.2018.11.014 · Cited by 1,264

Gut microbiota promotes obesity-associated liver cancer through pge2-mediated suppression of antitumor immunity.

Loo, T. M., Kamachi, F., Watanabe, Y., Yoshimoto, S., Kanda, H., Arai, Y., Nakajima-Takagi, Y., Iwama, A., Koga, T., Sugimoto, Y., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0932 · Cited by 478

EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

(2024) · Obesity Facts · doi:10.1159/000539371 · Cited by 522

New advances in the diagnosis and management of hepatocellular carcinoma

Yang, J. D., & Heimbach, J. K. (2020) · BMJ · doi:10.1136/bmj.m3544 · Cited by 397

Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma

Mak, L., Cruz-Ramón, V., Chinchilla-López, P., Torres, H. A., LoConte, N. K., Rice, J. P., Foxhall, L. E., Sturgis, E. M., Merrill, J. K., Bailey, H. H., et al. (2018) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_200939 · Cited by 246

Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression

Orci, L. A., Sanduzzi-Zamparelli, M., Caballol, B., Sapena, V., Colucci, N., Torres, F., Bruix, J., Reig, M., & Toso, C. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.05.002 · Cited by 218

Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma

Younossi, Z. M., & Henry, L. L. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100305 · Cited by 226

Hepatocellular carcinoma surveillance: An evidence-based approach

Harris, P. S., Hansen, R. M., Gray, M. E., Massoud, O. I., McGuire, B. M., & Shoreibah, M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i13.1550 · Cited by 221

Role of the Gut–Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship

Ohtani, N., & Kawada, N. (2019) · Hepatology Communications · doi:10.1002/hep4.1331 · Cited by 187

Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management

Cholankeril, G. T., Patel, R., Khurana, S., & Satapathy, S. K. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i11.533 · Cited by 185

Cancer Risk in Patients With Biopsy‐Confirmed Nonalcoholic Fatty Liver Disease: A Population‐Based Cohort Study

Simon, T. G., Roelstraete, B., Sharma, R., Khalili, H., Hagström, H., & Ludvigsson, J. F. (2021) · Hepatology · doi:10.1002/hep.31845 · Cited by 176

Should we undertake surveillance for HCC in patients with NAFLD?

Younes, R., & Bugianesi, E. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.006 · Cited by 165

Non-alcoholic fatty liver disease associated with hepatocellular carcinoma

Dhamija, E., Paul, S. B., & Kedia, S. (2019) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1456_17 · Cited by 139

Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?

Mikolašević, I., Filipec-Kanižaj, T., Mijić, M., Jakopčić, I., Milić, S., Hrstić, I., Sobočan, N., Štimac, D., & Burra, P. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i14.1491 · Cited by 131

Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Younossi, Z. M., Henry, L. L., Bush, H., & Mishra, A. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.08.001 · Cited by 111

A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk

Frenette, C. T., Isaacson, A., Bargellini, I., Saab, S., & Singal, A. G. (2019) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2019.04.005 · Cited by 113

Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome

Kasmari, A. J., Welch, A. R., Liu, G., LESLIE, D. L., McGarrity, T. J., & Riley, T. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.12.029 · Cited by 106

Diagnosis of non-alcoholic fatty liver disease (NAFLD)

Yki‐Järvinen, H. (2016) · Diabetologia · doi:10.1007/s00125-016-3944-1 · Cited by 103

Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis

Bengtsson, B., Stål, P., Wahlin, S., Björkström, N., & Hagström, H. (2019) · Liver international (Print) · doi:10.1111/liv.14087 · Cited by 84

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease

Wong, C. R., Nguyen, M., & Lim, J. K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i37.8294 · Cited by 98

The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease

Lee, T.-Y., Wu, J.-C., Yu, S.-H., Lin, J.-T., Wu, M.-S., & Wu, C.-Y. (2017) · International Journal of Cancer · doi:10.1002/ijc.30784 · Cited by 91

Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage

Masarone, M., Rosato, V., Aglitti, A., Bucci, T., Caruso, R., Salvatore, T., Sasso, F. C., Tripodi, M. F., & Persico, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178473 · Cited by 91

Current challenges and future directions for liver transplantation

Toniutto, P., Zanetto, A., Ferrarese, A., & Burra, P. (2016) · Liver International · doi:10.1111/liv.13255 · Cited by 87

Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma

Massoud, O. I., & Charlton, M. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.08.014 · Cited by 88

Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?

Lonardo, A., Ballestri, S., Mantovani, A., Nascimbeni, F., Lugari, S., & Targher, G. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.12.014 · Cited by 76

Clinical relevance of liver histopathology and different histological classifications of NASH in adults

Nascimbeni, F., Ballestri, S., Machado, M., Mantovani, A., Cortez-Pinto, H., Targher, G., & Lonardo, A. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1415756 · Cited by 56

Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma

Koh, Y. X., Tan, H. J., Liew, Y. X., Syn, N. L. X., Teo, J. Y., Lee, S. Y., Goh, B. K. P., Goh, G. B., & Chan, C. Y. (2019) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2019.07.012 · Cited by 55

Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?

Torres, M. C. P., Bodini, G., Furnari, M., Marabotto, E., Zentilin, P., Strazzabosco, M., & Giannini, E. G. (2020) · Cancers · doi:10.3390/cancers12061422 · Cited by 54

Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma

Koo, S.-Y., Park, E.-J., & Lee, C.-W. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0480-3 · Cited by 47

Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina

Piñero, F., Pages, J., Marciano, S., Fernández, N., Silva, J., Anders, M., Zerega, A., Ridruejo, E., Ameigeiras, B., D'Amico, C., et al. (2018) · World Journal of Hepatology · doi:10.4254/wjh.v10.i1.41 · Cited by 45

Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients

Argenziano, M. E., Kim, M. N., Montori, M., Bucchianico, A. D., Balducci, D., Ahn, S. H., & Svegliati‐Baroni, G. (2024) · Hepatology International · doi:10.1007/s12072-024-10692-4 · Cited by 52

TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis

Wang, X., Zeldin, S. M., Shi, H., Zhu, C., Saito, Y., Corey, K. E., Osganian, S. A., Remotti, H. E., Verna, E. C., Pajvani, U. B., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.11.031 · Cited by 41

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

Sumida, Y., Yoneda, M., Seko, Y., Ishiba, H., Hara, T., Toyoda, H., Yasuda, S., Kumada, T., Hayashi, H., Kobayashi, T., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10080579 · Cited by 32

The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)

Wang, Z., Li, S., Wang, R., Guo, L., Xu, D., Zhang, T., Xu, Y., Wang, W., Wang, M., Gan, Z., et al. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00164-4 · Cited by 34

Fatty Liver Through the Ages: Nonalcoholic Steatohepatitis

Younossi, Z. M., & Henry, L. L. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.12.010 · Cited by 35

Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI

Thompson, S. M., Garg, I., Ehman, E. C., Sheedy, S. P., Bookwalter, C. A., Carter, R. E., Roberts, L. R., & Venkatesh, S. K. (2018) · British Journal of Radiology · doi:10.1259/bjr.20180345 · Cited by 33

Outcomes after curative therapy for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a meta-analysis and review of current literature.

Chin, K. M., Prieto, M., Cheong, C., di Martino, M., Ielpo, B., Goh, B., & Koh, Y. (2021) · HPB · doi:10.1016/j.hpb.2021.01.009 · Cited by 30

Collagen Characterization in a Model of Nonalcoholic Steatohepatitis with Fibrosis; A Call for Development of Targeted Therapeutics

Pellicano, A. J., Spahn, K., Zhou, P., Goldberg, I. D., & Prakash Narayan, A. (2021) · Molecules · doi:10.3390/molecules26113316 · Cited by 32

The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma

Zhang, C., & Yang, M. J. (2021) · Cancers · doi:10.3390/cancers13153740 · Cited by 34

Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis

Aby, E. S., Phan, J., Truong, E., Grotts, J. F., & Saab, S. (2018) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001075 · Cited by 26

Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma

Piñero, F., Tanno, M., Soteras, G. A. A., Baña, M. T., Dirchwolf, M., Fassio, E., Ruf, A. E., Mengarelli, S., Borzi, S. M., Fernández, N., et al. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.06.003 · Cited by 25

Plasticity, heterogeneity, and multifunctionality of hepatic stellate cells in liver pathophysiology

Du, K., Jun, J. H., Dutta, R. K., & Diehl, A. M. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000411 · Cited by 26

Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH

Hwang, A., Shi, C., Zhu, E. Y., Naaz, F., Zhou, P., Rasheed, Z., Liu, X., Jung, L., Duan, B., Li, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198937 · Cited by 22

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Calitz, C., Pavlović, N., Rosenquist, J., Zagami, C., Samanta, A., & Heindryckx, F. (2020) · Journal of Visualized Experiments · doi:10.3791/61606 · Cited by 24

Hepatocellular carcinoma surveillance in Australia: current and future perspectives

Hui, S., Bell, S., Le, S. T. T., & Dev, A. T. (2023) · The Medical Journal of Australia · doi:10.5694/mja2.52124 · Cited by 23

A practical diagnostic approach to hepatic masses

Jain, D., & Vyas, M. (2018) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_578_17 · Cited by 21

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?

Demirtaş, C. Ö., & Brunetto, M. R. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i33.5536 · Cited by 20

The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma

Kogiso, T., & Tokushige, K. (2021) · Cancers · doi:10.3390/cancers13030516 · Cited by 20

MANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in sleeve gastrectomy and Roux-en Y gastric bypass

Billeter, A. T., Herrera, J. R. D. L. G., Scheurlen, K. M., Nickel, F., Billmann, F. G., & Müller-Stich, B. P. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0009 · Cited by 19

Non-alcoholic steatohepatitis and liver transplantation

Gitto, S., Vukotic, R., Vitale, G., Pirillo, M., Villa, E., & Andreoné, P. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.02.014 · Cited by 18

Is metabolic syndrome a risk factor in hepatectomy? A meta-analysis with subgroup analysis for histologically confirmed hepatic manifestations

Murtha-Lemekhova, A., Fuchs, J., Feiler, S., Schulz, E. R., Teroerde, M., Kalkum, E., Klotz, R., Billeter, A. T., Probst, P., & Hoffmann, K. (2022) · BMC Medicine · doi:10.1186/s12916-022-02239-x · Cited by 18

Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers

Deng, L. X., & Mehta, N. J. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06550-6 · Cited by 18

Older Age and Disease Duration Are Highly Associated with Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis

Dakhoul, L., Jones, K. R., Gawrieh, S., Ghabril, M., McShane, C., Vuppalanchi, R., Vilar‐Gómez, E., Nephew, L. D., Chalasani, N., & Lammert, C. S. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5441-5 · Cited by 16

Protein malnutrition during fetal programming induces fatty liver in adult male offspring rats

Campisano, S., Echarte, S. M., Podaza, E., & Chisari, A. (2017) · Journal of physiology and biochemistry · doi:10.1007/s13105-017-0549-1 · Cited by 15

Non-Cirrhotic Liver is Associated with Poor Prognosis of Hepatocellular Carcinoma: A Literature Review

Liu, Y., Li, H., Ye, N., Luo, C.-J., Hu, Y.-Y., Wu, H., & Gong, J. (2019) · Medical Science Monitor · doi:10.12659/msm.915722 · Cited by 15

All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma

van Mourik, H., Li, M., Baumgartner, S., Theys, J., & Shiri‐Sverdlov, R. (2022) · Biomedicines · doi:10.3390/biomedicines10102351 · Cited by 16

Linking Race, Cancer Outcomes, and Tissue Repair

Byun, J. S., Park, S., Caban, A., Jones, A. C., & Gardner, K. L. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.10.009 · Cited by 13

Liver Biopsy Hydroxyproline Content Is a Diagnostic for Hepatocellular Carcinoma in Murine Models of Nonalcoholic Steatohepatitis

Bissoondial, T. L., Han, Y., Mullan, S., Pabla, A. K., Spahn, K., Shi, S., Zheng, L., Zhou, P., Jiang, K., Prakash, N., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10100784 · Cited by 13

Surveillance for Hepatocellular Carcinoma

Marrero, J. A. (2020) · Clinics in Liver Disease · doi:10.1016/j.cld.2020.07.013 · Cited by 13

Hepatocellular Carcinoma

Jain, A., Mazer, B. L., Deng, Y., Ciarleglio, M. M., Jain, D., Taddei, T. H., & Zhang, X. (2021) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqab125 · Cited by 12

Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges

Samji, N. S., Verma, R., Keri, K., Singal, A. K., Ahmed, A., Rinella, M. E., Bernstein, D., Abdelmalek, M. F., & Satapathy, S. K. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05716-1 · Cited by 12

Hepatocellular Carcinoma in Non-cirrhotic Liver Arises with a More Advanced Tumoral Appearance: A Single-Center Cohort Study

Demirtaş, C. Ö., Tolu, T., Keklikkıran, Ç., Özdoğan, O. C., & Gündüz, F. (2021) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2021.20677 · Cited by 12

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Calitz, C., Pavlović, N., Rosenquist, J., Zagami, C., Samanta, A., & Heindryckx, F. (2020) · Journal of Visualized Experiments · doi:10.3791/61606-v · Cited by 12

Outcomes Following Resection of Hepatocellular Carcinoma in the Absence of Cirrhosis

Lewis, R. H., Glazer, E. S., Bittenbinder, D. M., O’Brien, T., Deneve, J. L., Shibata, D., Behrman, S. W., Vanatta, J. M., Satapathy, S. K., & Dickson, P. V. (2018) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-018-0152-x · Cited by 12

Hepatocellular carcinoma in non-alcoholic fatty liver disease with and without cirrhosis

Onzi, G., Moretti, F., Balbinot, S. S., Balbinot, R. Â., & Soldera, J. (2019) · Hepatoma Research · doi:10.20517/2394-5079.2018.114 · Cited by 11

The prognostic role of diabetes mellitus type 2 in the setting of hepatocellular carcinoma: a systematic review and meta-analysis

Mrzljak, A., Berković, M. C., Giovanardi, F., & Lai, Q. (2022) · Croatian Medical Journal · doi:10.3325/cmj.2022.63.176 · Cited by 10

Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a western perspective

Farrell, A., Ryan, M. C., & Howell, J. A. (2020) · Hepatoma Research · doi:10.20517/2394-5079.2019.019 · Cited by 9

The impact of metabolic syndrome (MetS) on surgical outcome for patients with mostly HBV‐related hepatocellular carcinoma (HCC) underwent hepatectomy

Tian, Y., Li, T., Qi, S., Alhourani, H., Luo, B., Chenqin, J., Fu, Q., Peng, Y., & Wu, J. (2020) · Journal of Surgical Oncology · doi:10.1002/jso.26055 · Cited by 9

Glycerol-3-phosphate Acyltransferase1 Is a Model-Agnostic Node in Nonalcoholic Fatty Liver Disease: Implications for Drug Development and Precision Medicine

Liao, K., Pellicano, A. J., Jiang, K., Prakash, N., Li, J., Bhutkar, S. P., Hu, Z., Ali, Q., Goldberg, I. D., & Prakash Narayan, A. (2020) · ACS Omega · doi:10.1021/acsomega.0c02350 · Cited by 9

[11C]acetate PET as a tool for diagnosis of liver steatosis

Nejabat, M., Leisser, A., Karanikas, G., Wadsak, W., Mitterhauser, M., Mayerhoefer, M. E., Kienbacher, C., Trauner, M. A., Hacker, M., & Haug, A. R. (2018) · Abdominal Radiology · doi:10.1007/s00261-018-1558-4 · Cited by 8

Therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced fatty liver disease, fibrosis and inflammation in rabbit.

Lin, P., Chen, C., Wallace, C. G., Chen, K., Chang, C., Chen, H., Sung, P., Lin, K., Ko, S., Sun, C., et al. (2017) · PubMed Central · Cited by 8

Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer

Kotulkar, M., Paine‐Cabrera, D., & Apte, U. M. (2024) · Seminars in Liver Disease · doi:10.1055/a-2349-7236 · Cited by 7

Sodium sulfite promotes the assembly and secretion of very low-density lipoprotein in HL-7702 hepatocytes

Bai, J., Lei, P., Zhao, C., Wang, Y., Yan, D., & Yang, S. (2015) · Toxicology Reports · doi:10.1016/j.toxrep.2015.12.005 · Cited by 7

Large hepatocellular carcinoma: Does fibrosis really impact prognosis after resection?

Golse, N., Bouyousfi, A. E., Marques, F., Bancel, B., Mohkam, K., Ducerf, C., Merle, P., Sebagh, M., Castaing, D., Cunha, A. S., et al. (2018) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2017.10.015 · Cited by 6

Perception of Non-Alcoholic Fatty Liver Disease: Real-Life Experience From Pakistan

Butt, N., Khan, M. A., Rai, L., Channa, R. H., Khemani, H., & Abbasi, A. (2021) · Cureus · doi:10.7759/cureus.16029 · Cited by 7

Non-Alcoholic Fatty Pancreas Disease: The Unsung Disease

Sevim, B. C., Chela, H. K., Ertugrul, H., Malik, L. S., Malik, S., Başar, Ö., Daglilar, E. S., Samiullah, S., Gaballah, A. H., & Tahan, V. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220929142905 · Cited by 5

Clinical Epidemiology of Chronic Liver Disease: Hepatocellular Carcinoma

Suraweera, D., Konyn, P., Vu, T., & Saab, S. (2018) · Clinical Epidemiology of Chronic Liver Diseases · doi:10.1007/978-3-319-94355-8_15 · Cited by 6

Pathological prognostic factors for post-resection survival in patients with hepatocellular carcinoma associated with non-alcoholic fatty liver disease

D’Silva, M., Na, H. Y., Cho, J. Y., Han, H., Yoon, Y., Lee, H. W., Lee, J. S., Lee, B., & Kim, M. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-707 · Cited by 4

Peretinoin as an adjuvant therapy for hepatocellular carcinoma

Tan, C.-K. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2016.1238303 · Cited by 5

Identification of disease-associated microRNA in a diet-induced model of nonalcoholic steatohepatitis

Bissoondial, T. L., Pellicano, A. J., Goldberg, I. D., & Prakash Narayan, A. (2021) · Molecular Omics · doi:10.1039/d1mo00274k · Cited by 4

Exploring the epidemiology and awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among health sciences students in an academic health care institute in India

Umasankari, S., Aishwarya, S., Aishwarya, S. K., Bhardwaj, S., Pavithra, R., Ray, S., & Vinodhini, V. M. (2024) · Metabolism Open · doi:10.1016/j.metop.2024.100325 · Cited by 4

How useful is the machine perfusion in liver transplantation? An answer from a national survey

Scalera, I., Carlis, R. D., Patrono, D., Gringeri, E., Olivieri, T., Pagano, D., Lai, Q., Rossi, M., Gruttadauria, S., Benedetto, F. D., et al. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.975150 · Cited by 4

Prognostic Accuracy of Transient Elastography-Based Predictors in Diabetes and Obesity: A Multicenter International Cohort Study

Jasty, V. S. J., Urias, E., Tiong, K. L. A., Aboona, M. B., Song, M. W., Faulkner, C., Devan, P., Neo, J. E., Wijarnpreecha, K., Wong, Y. J., et al. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08635-y · Cited by 4

Outcomes after laparoscopic or open liver resection for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: a propensity score-matching study

Watanabe, Y., Aikawa, M., Oshima, Y., Kato, T., Takase, K., Watanabe, Y., Okada, K., Okamoto, K., & Koyama, I. (2024) · Surgical Endoscopy · doi:10.1007/s00464-024-10937-1 · Cited by 3

Risk of Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis.

Charlton, M. (2018) · Europe PMC (PubMed Central) · Cited by 3

Long-term surgical outcomes of Non alcoholic fatty liver disease associated hepatocellular carcinoma

D’Silva, M., Cho, J. Y., Han, H., Yoon, Y., Lee, H. W., Lee, J. S., Lee, B., & Kim, M. (2022) · Surgical Oncology · doi:10.1016/j.suronc.2022.101730 · Cited by 4

Long-Term Survival and Curative-Intent Treatment in Hepatitis B or C Virus-Associated Hepatocellular Carcinoma Patients Diagnosed during Screening

Izzo, F., Mason, M. C., Silberfein, E. J., Massarweh, N. N., Hsu, C., Cao, H. S. T., Palaia, R., Piccirillo, M., Belli, A., Patrone, R., et al. (2022) · Biology · doi:10.3390/biology11111597 · Cited by 3

Etiology and Pathogenesis of Hepatocellular Carcinoma

Brar, T. S., Hilgenfeldt, E., & Soldevila‐Pico, C. (2017) · Molecular pathology library · doi:10.1007/978-3-319-68082-8_1 · Cited by 3

Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different?

Acharya, S., & Bopanna, S. (2020) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2020.04.004 · Cited by 3

A biomimetic liver model recapitulating bio-physical properties and tumour stroma interactions in hepatocellular carcinomaPreprint

Calitz, C., Pavlovic, N., Rosenquist, J., Zagami, C., Samanta, A., & Heindryckx, F. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.30.069823 · Cited by 3

Integrating diagnosis and therapy in hepatocellular carcinoma: advances in nanotheranostics

Shen, J., Wen, Y., Wu, S., & Tian, W. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1793834 · Cited by 2

Nonalcoholic Steatohepatitis and Liver Transplantation

Younossi, Z. M., & Henry, L. L. (2016) · Current Hepatology Reports · doi:10.1007/s11901-016-0298-6 · Cited by 2

Nonalcoholic Fatty Pancreatic Disease (NAFPD)

Juboori, A. A., Chela, H. K., Samiullah, S., & Tahan, V. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_25 · Cited by 2

[Medical-historical survey on epilepsy and older concepts about the therapy of epilepsy].

Vencovský, E. (1972) · PubMed · Cited by 1

Hepatocellular Carcinoma in Nonalcoholic Steatohepatitis

Koppe, S., & Arshad, H. M. S. (2017) · Digestive Disease Interventions · doi:10.1055/s-0037-1603572

Volumineux carcinome hépatocellulaire : quel est l’impact de la fibrose sur le pronostic après résection ?

Golse, N., Bouyousfi, A. E., Marques, F., Bancel, B., Mohkam, K., Ducerf, C., Merle, P., Sebagh, M., Castaing, D., Cunha, A. S., et al. (2018) · Journal de Chirurgie Viscérale · doi:10.1016/j.jchirv.2017.09.005

Hepatocellular Cancer Induced by Infection

Kaplan, D. E., Chang, K., & Sanyal, A. J. (2019) · Current cancer research · doi:10.1007/978-3-030-04155-7_12

A Case of Early Multiply Recurred Hepatocellular Carcinoma after Surgical Resection in Patient Who Unprecedented Chronic Liver Disease

Choi, W. Y., Jang, B. K., Chung, W. J., & Hwang, J. S. (2015) · Journal of Liver Cancer · doi:10.17998/jlc.15.2.112

Non‐alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis

Ertle, J., Dechêne, A., Sowa, J., Penndorf, V., Herzer, K., Kaiser, G. M., Schlaak, J., Gerken, G., Syn, W., & Canbay, A. E. (2010) · International Journal of Cancer · doi:10.1002/ijc.25797 · Cited by 524

Nonalcoholic Fatty Liver Disease progresses to HCC in the absence of apparent Cirrhosis

Ertle, J., Dechêne, A., Sowa, J., Penndorf, V., Herzer, K., Kaiser, G. M., Schlaak, J., Gerken, G., & Canbay, A. E. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0030-1269537 · Cited by 10

Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?

Guzman, G., Brunt, E. M., Petrovic, L. M., Chejfec, G., Layden, T. J., & Cotler, S. J. (2008) · Archives of Pathology & Laboratory Medicine · doi:10.5858/132.11.1761 · Cited by 212

Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude.

Pocha, C., Kolly, P., & Dufour, J.-F. (2015) · Open Access CRIS of the University of Bern · doi:10.7892/boris.77718

NAFLD-Associated Hepatocellular Carcinoma: a Threat to Patients with Metabolic Disorders

Sasdelli, A. S., Brodosi, L., & Giulio, M. (2016) · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)